Springfield, MO

Log in Subscribe

Pfizer pens $10.6B acquisition

Posted online

Pfizer Inc. announced it would buy Array Biopharma for $16.4 billion in cash.

Array makes approved treatments for skin cancer.

"(The acquisition) sets the stage to create a potentially industry-leading franchise for colorectal cancer alongside Pfizer's existing expertise in breast and prostate cancers," Pfizer CEO Albert Bourla said.

Read more from Reuters.


No comments on this story |
Please log in to add your comment
Editors' Pick
First SBC taproom to debut this summer, officials say

Rogersville venture to lead with Willard’s to follow by early fall.

Most Read
Update cookies preferences